Recombinant DNA Technology Market to Rise at more than 8% CAGR during 2019-2025, with Top Players (Thermo Fisher Scientific, Biogen, Sanofi Pasteur, Merck & Co., Pfizer, Profacgen, Amgen, Monsanto Company)

Global Recombinant DNA Technology Market 2019-2025: Global Recombinant DNA Technology Market, by Product Type (Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, and Gene Editing), by Application (Therapeutics, Agriculture, and Research), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).

The global recombinant DNA technology market was valued at US$ 106.8 billion in 2017, and is set to grow at a healthy CAGR of 7.9% during forecast period (2017 – 2025).

Get a Quick Free Sample report at https://decisionmarketreports.com/request-sample?productID=982959&utm_source=sd&utm_medium=OpenPR

Recombinant DNA technology has allowed the transfer of desired characteristics which is useful to improve the existing systems by controlling expression of target genes. Recombinant DNA technology allows mass production of therapeutic proteins, which are characterized by high level of consistency and stability. The technology has multidisciplinary applications and potential to deal with important aspects of life, for instance, improving health, and enhancing food resources. The genetically modified plants have augmented resistance to viruses and insect attacks, enhanced product yield, and shown increased adaptability for better survival.

Market Dynamics
Rapid technological advancements in the field of genetic engineering to deliver highly efficient therapeutics for disease management and in the field of agriculture are major driving factors for growth of recombinant DNA technology market. For instance, Bac-to-Bac Baculovirus Expression Systems offers a quick and efficient method to produce recombinant baculovirus and can express the desired genes in insect cells and provide high yields of recombinant protein that speeds up the cloning reaction as compared to the time-consuming restriction enzyme cloning, which takes 2–3 days. Also, in 2016, a BioAg Alliance was formed between Monsanto and Novozymes A/S, to improve crop harvests by using products containing naturally-occurring microbes to boost agricultural productivity and expand its product portfolio. However, the adoption of non-biologic therapeutics and higher complexity of the genetically engineered products such as stability of the cell lines, requirement of skilled professionals, and optimum temperature are the factors hindering the market growth.

Browse Complete Report with Table of Content at https://decisionmarketreports.com/market-reports/982959/recombinant-dna-technology-market?utm_source=sd&utm_medium=OpenPR

Key features of the study:
• This report provides in-depth analysis of recombinant DNA technology market and provides market size (US$ Billion) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global recombinant DNA technology market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Biogen, Inc., Sanofi Pasteur, Merck & Co., Inc., Pfizer, Inc., Profacgen, Amgen, Inc., and Monsanto Company
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global recombinant DNA technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the recombinant DNA technology market

Detailed Segmentation:
• Global Recombinant DNA Technology Market, By Product Type:
o Recombinant Protein Drugs
 Insulin
 Human Growth Hormone
 Erythropoietin
 Interferon
 Blood Factors
 Colony Stimulating Factors
 Fusion Proteins
 Others
o Vaccines
o Genetically Modified Crops
o Expression Systems
 Prokaryotic Cells
 Mammalian Cells
 Yeats
 Insect
 Others
o Cell and Gene Therapy
o Gene Editing
• Global Recombinant DNA Technology Market, By Application:
o Therapeutics
o Agriculture
o Research
• Global Recombinant DNA Technology Market, By Geography:

Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations

2. Market Purview
o Report Description
 Market Definition and Scope
o Executive Summary
 Market Snippet, By Product Type
 Market Snippet, By Application
 Market Snippet, By Region
o Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
 Drivers
 Restraints
 Market Opportunities
 Industry Trends
o Regulatory Scenario
o Key Highlights
o PEST Analysis
o Epidemiology
o Impact Analysis
o PORTER’s Analysis

4. Global Recombinant DNA Technology Market, By Product Type, 2015 – 2025, (US$ Billion)
o Introduction
 Market Share Analysis, 2015 and 2025 (%)
 Y-o-Y Growth Analysis, 2016 – 2025
 Segment Trends
o Recombinant Protein Drugs
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
 Segment Trends
 Insulin
 Human Growth Hormone
 Erythropoietin
 Interferon
 Blood Factors
 Colony Stimulating Factors
 Fusion Proteins
 Others
o Vaccines
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
o Genetically Modified Crops
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
o Expression Systems
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
 Segment Trends
 Prokaryotic Cells
 Mammalian Cells
 Yeats
 Insect
 Others
o Cell and Gene Therapy
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
o Gene Editing
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)

5. Global Recombinant DNA Technology Market, By Application, 2015 – 2025, (US$ Billion)

...Continued

Request a In-depth Insights PDF Sample Brochure at https://decisionmarketreports.com/request-sample?productID=982959&utm_source=sd&utm_medium=OpenPR

About Us
Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

Contact Us
Gasper James
304, S Jones Blvd,
Las Vegas,
NV 89107, USA
US Toll Free +1-866-605-1052
Email: sales@decisionmarketreports.com
Web: https://decisionmarketreports.com

This release was published on openPR.